BioCurex Inc. Reports On Presentation of RECAF Results At the ‘XII International Symposium On Biology and Clinical Usefulness of Tumor Markers’ Held in Europe

RICHMOND, British Columbia, Feb. 19, 2009 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today reported on its RECAF presentation at this international cancer congress held in Barcelona, Spain.